Biotech

All Articles

Basilea scores $268M BARDA funding for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work building new antifungals has actually acquired a considerable boost fr...

Capricor offers Europe civil rights to late-stage DMD treatment for $35M

.Possessing actually gathered up the U.S. civil rights to Capricor Therapies' late-stage Duchenne mu...

FDA junks adcomm for Applied's unusual ailment drug

.After pushing the decision date for Applied Therapies' metabolic condition medication govorestat, t...

Novo inks $600M NanoVation bargain to examine hereditary medicines ex-liver

.Novo Nordisk is actually proceeding its own push right into genetic medications, agreeing to pay Na...

Innovent links cytokine to colorectal cancer cells responses

.Innovent Biologics has made the case that its gate inhibitor-cytokine blend protein possesses a fut...

Merck, Daiichi ADC reaches objective in phase 3 lung cancer cells research

.A phase 3 trial of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina deepens artificial intelligence focus with collab to decide on cancer cells targets

.Five months after Rakovina Therapeutics pivoted towards expert system, the cancer-focused biotech h...

Ascendis' dwarfism medicine favorites in stage 3, intimidates BioMarin

.Ascendis Pharma has actually become a potential threat to BioMarin's Voxzogo, mentioning period 3 d...

Despite ph. 3 skip, Alkeus observes path in advance for eye illness asset

.Though Alkeus Pharmaceuticals' dental eye health condition possession stopped working to considerab...

Kairos goes social along with $6M IPO to fund trials of cancer cells medication

.With a trio of biotechs striking the Nasdaq on Friday, it was quick and easy to overlook a smaller-...